125 related articles for article (PubMed ID: 19592338)
21. Psoriatic arthritis.
Durham LE; Taams LS; Kirkham BW
Br J Hosp Med (Lond); 2016 Jul; 77(7):C102-8. PubMed ID: 27388392
[No Abstract] [Full Text] [Related]
22. Therapies for dactylitis in psoriatic arthritis. A systematic review.
Helliwell PS
J Rheumatol; 2006 Jul; 33(7):1439-41. PubMed ID: 16724369
[TBL] [Abstract][Full Text] [Related]
23. Acute generalized skin eruption due to adalimumab: report of two cases.
Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
[No Abstract] [Full Text] [Related]
24. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
[No Abstract] [Full Text] [Related]
25. Treatment of psoriatic arthritis.
Williamson L; Dockerty JL; Dalbeth N
Rheumatology (Oxford); 2004 Jul; 43(7):938-9. PubMed ID: 15213344
[No Abstract] [Full Text] [Related]
26. Long term treatment of psoriatic arthritis with infliximab.
Yazdani-Biuki B; Wohlfahrt K; Mulabecirovic A; Mueller T; Hermann J; Graninger WB; Brezinschek HP; Brezinschek RI
Ann Rheum Dis; 2004 Nov; 63(11):1531-2; author reply 1532. PubMed ID: 15479917
[No Abstract] [Full Text] [Related]
27. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Gottlieb A; Korman NJ; Gordon KB; Feldman SR; Lebwohl M; Koo JY; Van Voorhees AS; Elmets CA; Leonardi CL; Beutner KR; Bhushan R; Menter A
J Am Acad Dermatol; 2008 May; 58(5):851-64. PubMed ID: 18423261
[TBL] [Abstract][Full Text] [Related]
28. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
[No Abstract] [Full Text] [Related]
29. Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis.
Kirson NY; Rao S; Birnbaum HG; Kantor E; Wei RS; Cifaldi M
J Med Econ; 2013; 16(4):479-89. PubMed ID: 23339434
[TBL] [Abstract][Full Text] [Related]
30. Amyotrophic lateral sclerosis developing during adalimumab therapy for psoriatic arthritis.
Bougea A; Anagnostou E; Stamboulis E; Kararizou E
Rev Neurol (Paris); 2014 Mar; 170(3):228-9. PubMed ID: 24656415
[No Abstract] [Full Text] [Related]
31. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
Kavanaugh A; Tutuncu Z; Catalan-Sanchez T
Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453
[TBL] [Abstract][Full Text] [Related]
32. [Psoriatic arthritis: what the dermatologist needs to know, Part 2].
López-Ferrer A; Torrente-Segarra V; Puig L
Actas Dermosifiliogr; 2010 Nov; 101(9):742-8. PubMed ID: 21034704
[TBL] [Abstract][Full Text] [Related]
33. Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
Vander Cruyssen B; De Keyser F; Kruithof E; Mielants H; Van den Bosch F
Ann Rheum Dis; 2007 Jan; 66(1):138-40. PubMed ID: 17178763
[No Abstract] [Full Text] [Related]
34. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response.
Rinaldi F; Provenzano G; Termini A; Spinello M; La Seta F
Ann Rheum Dis; 2005 Sep; 64(9):1375-6. PubMed ID: 16100346
[No Abstract] [Full Text] [Related]
35. Biological therapy for psoriatic arthritis in clinical practice: outcomes up to 2 years.
Virkki LM; Sumathikutty BC; Aarnio M; Valleala H; Heikkilä R; Kauppi M; Karstila K; Pirilä L; Ekman P; Salomaa S; Romu M; Seppälä J; Niinisalo H; Konttinen YT; Nordström DC
J Rheumatol; 2010 Nov; 37(11):2362-8. PubMed ID: 20716655
[TBL] [Abstract][Full Text] [Related]
36. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.
Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L
Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209
[No Abstract] [Full Text] [Related]
37. Occurrence of penile intraepithelial neoplasia following adalimumab treatment for psoriatic arthritis.
Kreuter A; Meyer MF; Wieland U
Arch Dermatol; 2011 Aug; 147(8):1001-2. PubMed ID: 21844477
[No Abstract] [Full Text] [Related]
38. Hyperpigmentation of the face following adalimumab treatment.
Blomberg M; Zachariae CO; Grønhøj F
Acta Derm Venereol; 2009; 89(5):546-7. PubMed ID: 19734995
[No Abstract] [Full Text] [Related]
39. [The role of biological agents in the treatment of psoriatic arthritis, literature review].
Koó E; Brodszky V; Péntek M; Ujfalussy I; Nagy MB; Gulácsi L
Orv Hetil; 2006 Oct; 147(41):1963-70. PubMed ID: 17120686
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
